A proposed settlement of about $7.25 billion for lawsuits alleging that Monsanto’s Roundup weedkiller causes cancer could face delays, according to reporting from multiple outlets. The deal would cover thousands of claims made by plaintiffs who argue they were not properly warned about the product’s potential cancer risks. The settlement is contingent on legal approval, and the timing may be affected by ongoing court proceedings and objections raised by parties in the litigation. While the proposed amount is described consistently across sources, both outlets emphasize that a legal fight could extend the schedule for final approval and administration of the settlement. The delay risk reflects that the settlement must navigate judicial review and any disputes that may be brought before the courts before funds can be distributed. The proposed settlement’s scope and purpose remain the same in the coverage: resolving claims related to alleged failures to provide adequate warnings about cancer-related harms linked to Roundup.